Testosterone Therapy Raises Risk of Venous Thromboembolism
Study reveals an approximately 2-fold increased odds of venous thromboembolism associated with testosterone therapy in men with or without hypogonadism
Hypogonadism
HYPOGONADISM
Screening for Opioid-Related Low Testosterone Underused
Rates of screening, treatment for low testosterone higher for prolonged versus short-term opioid users
Can Testosterone Therapy Lower Prostate Cancer Risk?
In a study, investigators observed a reduced probability of prostate cancer in nondiabetic men with greater use of testosterone therapy.
Position Statement Clarifies Benefits of Testosterone Therapy for Women
Testosterone only recommended for postmenopausal women with hypoactive sexual desire dysfunction
Erectile Dysfunction in Former Football Players Linked to Concussions
A study of former US professional football players found that the risk of self-reported indicators of low testosterone and erectile dysfunction increased with each successive quartile of concussion symptom score.
Review Supports Testosterone for Low Sexual Desire in Women
Beneficial effects for postmenopausal women, with preference for nonoral testosterone administration
Testosterone Replacement Therapy May Increase Cardiovascular Risk
Increased risk in men on TRT for composite of heart attack, ischemic stroke, transient ischemic attack
Managing Opioid-Induced Androgen Deficiency
The increased opioid use has been associated with a rising incidence of opioid-induced endocrinopathy, most commonly in the form of androgen deficiency.
Testosterone Undecanoate May Reduce CV Morbidity, Mortality in Men With Hypogonadism, Type 2 Diabetes
Long-term treatment with testosterone undecanoate was associated with reduced cardiovascular morbidity and mortality in patients with hypogonadism and type 2 diabetes.
Selective Estrogen Receptor Modulators May Be Effective for Male Infertility
Selective estrogen receptor modulators (SERMs) may be effective for treating male infertility, according to a recent systematic review and meta-analysis published in Expert Opinion on Pharmacotherapy. SERMs are compounds that exhibit tissue-selective estrogen receptor agonist and antagonist activity. Clomiphene citrate and tamoxifen are two agents commonly used for the off-label management of male infertility. To…
Want to read more?
Please login or register first to view this content.